EVEROLIMUS AND SORAFENIB FOR RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION

被引：0
|
作者：
De Simone, Paolo [1 ]
Pezzati, Daniele [1 ]
Lai, Quirino [1 ]
Ghinolfi, Davide [1 ]
Coletti, Laura [1 ]
Precisi, Arianna [1 ]
Leonardi, Giulia [1 ]
Carrai, Paola [1 ]
Filipponi, Franco [1 ]
机构：
[1] Univ Pisa, Med Sch Hosp, I-56100 Pisa, Italy
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [41] Sorafenib for hepatocellular carcinoma before liver transplantation
    Adair, Anya
    Wigmore, Stephen J.
    TRANSPLANT INTERNATIONAL, 2013, 26 (11) : E100 - E101
  • [42] Sorafenib for Hepatocellular Carcinoma after Living Donor Liver Transplantation.
    Chen, Chao-Long
    Concejero, Allan M.
    Lin, Chih-Che
    Wang, Chih-Chi
    Wang, Shih-Ho
    Liu, Yueh-Wei
    Yong, Chee-Chien
    LIVER TRANSPLANTATION, 2012, 18 : S161 - S161
  • [43] Hepatocellular Carcinoma: Sorafenib Before Liver Transplantation?
    Braillon, Alain
    HEPATOLOGY, 2010, 51 (06) : 2232 - 2233
  • [44] Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation
    de'Angelis, Nicola
    Landi, Filippo
    Nencioni, Marco
    Palen, Anais
    Lahat, Eylon
    Salloum, Chady
    Compagnon, Philippe
    Lim, Chetana
    Costentin, Charlotte
    Calderaro, Julien
    Luciani, Alain
    Feray, Cyrille
    Azoulay, Daniel
    PROGRESS IN TRANSPLANTATION, 2016, 26 (04) : 348 - 355
  • [45] Sorafenib for recurrent hepatocellular carcinoma after liver transplantation: Intrinsic resistance or not?
    Tovoli, Francesco
    Sansone, Vito
    Di Costanzo, Giovan Giuseppe
    Magini, Giulia
    Sacco, Rodolfo
    Pressiani, Tiziana
    Trevisani, Franco
    Tortora, Raffaella
    Bucci, Laura
    Luca, Maria Grazia
    Bolondi, Luigi
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E619 - E620
  • [46] High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients
    Nitta, Hidetoshi
    Younes, Aline
    El-domiaty, Nada
    Karam, Vincent
    Sobesky, Rodolphe
    Vibert, Eric
    Coilly, Audrey
    Maria Antonini, Teresa
    De Martin, Eleonora
    Cherqui, Daniel
    Baba, Hideo
    Rosmorduc, Olivier
    Adam, Rene
    Samuel, Didier
    Saliba, Faouzi
    TRANSPLANT INTERNATIONAL, 2021, 34 (07) : 1293 - 1305
  • [47] Use of sorafenib in recurrent hepatocellular carcinoma (HCC) after liver transplantation
    Chiu, Joanne Wing-Yan
    Yau, Thomas Cheung
    Cheung, Tan To
    Chan, Albert
    Chok, Siu-Ho
    Dai, Wing-Chiu
    Leung, Roland Ching-Yu
    Chan, See-Ching
    Lo, Chung-Mau
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [48] EVEROLIMUS IN LIVER TRANSPLANTATION TO PREVENT HEPATOCELLULAR CARCINOMA RECURRENCE IN THE PRESENCE OF EXTENDED MILAN CRITERIA
    Houssel, P.
    Latournerie, M.
    Jezequel, C.
    Bardou-Jacquet, E.
    Patrizi, A.
    Rayar, M.
    Lakehal, M.
    Boudjema, K.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S72 - S72
  • [49] The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence
    Sinakos, Emmanouil
    Selvaggi, Gennaro
    Papalavrentios, Lavrentis
    Tzakis, Andreas
    Akriviadis, Evangelos
    ANNALS OF GASTROENTEROLOGY, 2011, 24 (03): : 228 - 230
  • [50] Liver transplantation for recurrence after resection of solitary hepatocellular carcinoma
    Majno, PE
    Adam, R
    Mazzaferro, V
    Regalia, E
    Mentha, G
    Moret, P
    Bismuth, H
    TRANSPLANTATION, 1999, 67 (09) : S579 - S579
12345